TOP JOURNAL OF CLINICAL BREAST CANCER SECRETS

The American Society of Clinical Oncology–Faculty of American Pathologists (ASCO–CAP) pointers have continued to evolve to improve the precision and clinical utility of HER2 screening by delivering distinct algorithms15,16. In parallel with current tactics, novel ways to quantify HER2 degrees or standardize methods are increasingly being inves